CPGShield resources · Print artwork requirements
There is a part of cosmetic labeling that sounds almost absurdly specific until it causes a real packaging problem:
the bottom 30% of the principal display panel.
For many cosmetics sold in an outer container, FDA's labeling guide says the net quantity of contents must appear within the bottom 30% of the principal display panel.
The bottom-location requirement is waived when the principal display panel is 5 square inches or less.
That means moving one short line of text for design reasons can change an otherwise acceptable layout.
The principal display panel, or PDP, is the portion of the package most likely to be displayed, presented, shown, or examined under normal retail conditions.
For a standard box, it is often the front panel.
For other package shapes, calculating the PDP area can require more thought.
FDA's regulations in 21 CFR 701.10 and related labeling guidance explain how the PDP is determined for different package forms.
The PDP matters because major required information lives there.
That includes the product identity and net quantity of contents.
The net quantity statement tells the consumer how much product is actually in the package.
Examples include:
FDA does not want that information hidden among marketing claims.
The rules therefore address:
The bottom-30% rule is only one part of the presentation standard. The rest of it is covered in how small the text on a cosmetic label can legally be.
FDA's guide says the bottom location requirement is waived for PDPs of 5 square inches or less.
This does not mean a tiny package is exempt from every net-quantity rule.
It means that specific bottom-30% placement requirement changes.
Other requirements can still apply.
This is why blanket statements like “net weight must always be at the bottom” are incomplete.
The correct answer depends on the package.
FDA also says the net quantity declaration generally should appear in lines parallel to the base on which the package rests.
Again, that sounds minor.
Then a designer rotates the statement 90 degrees to fit a narrow vertical panel.
The design may look clean.
The compliance question just changed.
The net quantity declaration is supposed to be a distinct item.
FDA's guide explains that the statement must be separated from surrounding printed matter by specified spacing tied to the height and width of the lettering.
So packing:
Net Wt. 1 oz | Vegan | Cruelty-Free | 30 mL
into one crowded line may create more than a visual-design problem.
Required information needs enough separation to remain distinct.
Placement is only half the issue.
FDA's minimum net-quantity letter height changes with the area of the principal display panel.
The guide summarizes:
That creates an unusual effect:
Changing the dimensions of the box can change both where the statement belongs and how large it must be.
The formula did not change.
The label wording did not change.
The package geometry changed-and therefore the compliance analysis changed.
FDA provides special treatment for some very small cosmetics and decorative containers.
For example, the PDP may sometimes be a tear-away tag, tape, or display card under specified conditions.
Certain very small packages may also qualify for exemptions from inner-container net quantity declarations when properly labeled through an outer package or display card.
These rules are one reason a universal label template is dangerous.
A 50 mL moisturizer carton and a tiny cosmetic pencil should not necessarily be reviewed as though they were the same physical package.
Picture a normal workflow:
Every person did their job.
The label can still drift away from the reviewed version.
That is why the final compliance check should be tied to final artwork-not an earlier Word document.
For cosmetics sold at retail in an outer container, FDA's guide generally requires the statement within the bottom 30% of the outer-container PDP, with the bottom-location requirement waived for PDPs of 5 square inches or less.
The principal display panel is the part of the package most likely to be displayed or examined under normal retail conditions.
The required outer-container net quantity declaration belongs on the principal display panel. Additional non-deceptive quantity information may be permitted elsewhere, but it does not replace the required PDP declaration.
FDA's guide describes the declaration as easily legible boldface type in distinct contrast to the background and other matter.
Yes. PDP area affects the minimum letter height and can affect the placement analysis.
That is exactly why CPGShield evaluates more than extracted words.
For print-ready PDFs, CPGShield can check measurable label properties such as type size and panel placement while also reviewing the regulatory content of the cosmetic label.
The goal is to catch the issue while “move this line down” is still a free edit.
→ Upload the final cosmetic label to CPGShield before print
A text scan is free. Measuring supported print-ready PDFs costs one check credit; supported PDF corrections cost one additional check credit. Unsupported or unreadable artwork checks remain unverified and require review before printing.
Fix pixels, not pallets.
This article is educational and does not constitute legal advice.
Free cosmetic label compliance check. No demo required, no card. CPGShield LLC provides independent screening. We are not affiliated with, endorsed by, or acting for any retailer, brand, agency or organization we name.